These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 16374840

  • 1. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J, Qiao L, Zimmermann L, Ebert MP, Zhang H, Lin W, Röcken C, Malfertheiner P, Farrell GC.
    Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
    Yoshizawa K, Cioca DP, Kawa S, Tanaka E, Kiyosawa K.
    Cancer; 2002 Nov 15; 95(10):2243-51. PubMed ID: 12412180
    [Abstract] [Full Text] [Related]

  • 3. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
    Motomura W, Okumura T, Takahashi N, Obara T, Kohgo Y.
    Cancer Res; 2000 Oct 01; 60(19):5558-64. PubMed ID: 11034103
    [Abstract] [Full Text] [Related]

  • 4. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
    Yu HN, Lee YR, Noh EM, Lee KS, Kim JS, Song EK, Han MK, Lee YC, Kwon KB, Lee SJ, Youn HJ, Jung SH.
    Cell Biol Int; 2008 Aug 01; 32(8):906-12. PubMed ID: 18474441
    [Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG, Zhang ZW, Xin DQ, Shi CJ, Wu JP, Guo YL, Guan YF.
    Acta Pharmacol Sin; 2005 Jun 01; 26(6):753-61. PubMed ID: 15916743
    [Abstract] [Full Text] [Related]

  • 6. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E, Kawaguchi T, Sasatomi K, Kimura R, Hashimoto O, Ueno T, Yano H, Kojiro M, Sata M.
    Hepatology; 2001 May 01; 33(5):1087-97. PubMed ID: 11343236
    [Abstract] [Full Text] [Related]

  • 7. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
    Koga H, Harada M, Ohtsubo M, Shishido S, Kumemura H, Hanada S, Taniguchi E, Yamashita K, Kumashiro R, Ueno T, Sata M.
    Hepatology; 2003 May 01; 37(5):1086-96. PubMed ID: 12717389
    [Abstract] [Full Text] [Related]

  • 8. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS, Chen WC, Bai X, Wang YD.
    J Dig Dis; 2007 May 01; 8(2):82-8. PubMed ID: 17532820
    [Abstract] [Full Text] [Related]

  • 9. The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest.
    Fujii D, Yoshida K, Tanabe K, Hihara J, Toge T.
    Anticancer Res; 2004 May 01; 24(3a):1409-16. PubMed ID: 15274302
    [Abstract] [Full Text] [Related]

  • 10. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
    Shim J, Kim BH, Kim YI, Kim KY, Hwangbo Y, Jang JY, Dong SH, Kim HJ, Chang YW, Chang R.
    Int J Oncol; 2010 Jan 01; 36(1):223-31. PubMed ID: 19956851
    [Abstract] [Full Text] [Related]

  • 11. Phorbol ester potentiates the growth inhibitory effects of troglitazone via up-regulation of PPARgamma in A549 cells.
    Kim HJ, Woo IS, Kang ES, Eun SY, Kim GH, Ham SA, Kim HJ, Lee JH, Chang KC, Kim JH, Lee HT, Seo HG.
    Biochem Biophys Res Commun; 2006 Oct 20; 349(2):660-7. PubMed ID: 16945329
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
    Hsu MC, Huang CC, Chang HC, Hu TH, Hung WC.
    Clin Cancer Res; 2008 Jul 01; 14(13):4045-52. PubMed ID: 18593980
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
    Cui W, Yu CH, Hu KQ.
    Clin Cancer Res; 2005 Nov 15; 11(22):8213-21. PubMed ID: 16299255
    [Abstract] [Full Text] [Related]

  • 14. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
    Kim KR, Choi HN, Lee HJ, Baek HA, Park HS, Jang KY, Chung MJ, Moon WS.
    Oncol Rep; 2007 Oct 15; 18(4):825-32. PubMed ID: 17786342
    [Abstract] [Full Text] [Related]

  • 15. Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2.
    Qiao L, Dai Y, Gu Q, Chan KW, Ma J, Lan HY, Zou B, Rocken C, Ebert MP, Wong BC.
    Cancer Lett; 2008 Sep 18; 268(2):260-71. PubMed ID: 18477501
    [Abstract] [Full Text] [Related]

  • 16. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
    Li M, Lee TW, Mok TS, Warner TD, Yim AP, Chen GG.
    J Cell Biochem; 2005 Nov 01; 96(4):760-74. PubMed ID: 16149072
    [Abstract] [Full Text] [Related]

  • 17. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
    Kubota T, Koshizuka K, Williamson EA, Asou H, Said JW, Holden S, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3344-52. PubMed ID: 9699665
    [Abstract] [Full Text] [Related]

  • 18. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
    Li M, Lee TW, Yim AP, Mok TS, Chen GG.
    J Cell Physiol; 2006 Nov 01; 209(2):428-38. PubMed ID: 16883598
    [Abstract] [Full Text] [Related]

  • 19. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.
    Yoshida K, Tanabe K, Fujii D, Oue N, Yasui W, Toge T.
    Anticancer Res; 2003 Nov 01; 23(1A):267-73. PubMed ID: 12680223
    [Abstract] [Full Text] [Related]

  • 20. Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18).
    Takenokuchi M, Saigo K, Nakamachi Y, Kawano S, Hashimoto M, Fujioka T, Koizumi T, Tatsumi E, Kumagai S.
    Acta Haematol; 2006 Nov 01; 116(1):30-40. PubMed ID: 16809887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.